<DOC>
	<DOC>NCT00291213</DOC>
	<brief_summary>This is a placebo-controlled study designed to learn if levetiracetam is effective for tardive dyskinesia.</brief_summary>
	<brief_title>Levetiracetam Treatment of Tardive Dyskinesia</brief_title>
	<detailed_description />
	<mesh_term>Dyskinesias</mesh_term>
	<mesh_term>Movement Disorders</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>meet Glazer Morgenstern criteria for TD none</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>